Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
105 Bradford Road, Suite 420, Wexford, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Bull Horn Holdings Corp. (to 10/28/2022)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % +86.1%
Debt-to-equity 112 % -8.8%
Return On Assets -205 % -56.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.1 M shares +76.6%
Common Stock, Shares, Outstanding 36.4 M shares +74%
Entity Public Float 28.8 M USD -42.4%
Common Stock, Value, Issued 3.64 K USD +74%
Weighted Average Number of Shares Outstanding, Basic 35.5 M shares +77%
Weighted Average Number of Shares Outstanding, Diluted 35.5 M shares +77%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 7.33 M USD +5281%
Selling and Marketing Expense 12.4 K USD +334%
General and Administrative Expense 3.88 M USD -20.2%
Operating Income (Loss) -17.9 M USD +28.6%
Nonoperating Income (Expense) 1.56 M USD +94.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3 M USD +38.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.3 M USD +38.1%
Earnings Per Share, Basic -0.51 USD/shares +66.2%
Earnings Per Share, Diluted -0.51 USD/shares +66.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8 K USD -97.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 6.88 M USD +202%
Property, Plant and Equipment, Net 11.1 K USD -9.3%
Operating Lease, Right-of-Use Asset 88.4 K USD +80.3%
Assets 9.39 M USD +58.1%
Accounts Payable, Current 1.37 M USD +463%
Accrued Liabilities, Current 719 K USD +144%
Liabilities, Current 4.3 M USD +77.8%
Operating Lease, Liability, Noncurrent 61.2 K USD +316%
Liabilities 5.03 M USD -1.2%
Retained Earnings (Accumulated Deficit) -90.4 M USD -22%
Stockholders' Equity Attributable to Parent 4.36 M USD +415%
Liabilities and Equity 9.39 M USD +58.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9 M USD -12.9%
Net Cash Provided by (Used in) Financing Activities 1.56 M USD
Net Cash Provided by (Used in) Investing Activities -100 K USD
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 36.4 M shares +74%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.03 M USD -51.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 23.1 M USD +23.2%
Deferred Tax Assets, Gross 23.1 M USD +23.2%
Operating Lease, Liability 90.1 K USD +94.8%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 103 K USD +96.8%
Property, Plant and Equipment, Gross 25.2 K USD 0%
Operating Lease, Liability, Current 29 K USD -8.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46 K USD +146%
Lessee, Operating Lease, Liability, to be Paid, Year One 34.1 K USD +1.14%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.2 K USD +112%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.2 K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.5 M USD +21.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 94.7 M USD +27.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 250 K USD -0.04%
Interest Expense 277 K USD +42.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%